[144] CoreWeave, Inc. SEC Filing

Rhea-AI Filing Summary

CoreWeave, Inc. filed a Form 144 notifying the proposed sale of 61,810 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $8,273,268.50. The filing lists the issuer's total outstanding shares as 370,470,348 and an approximate sale date of 10/07/2025. The shares to be sold were acquired as Restricted Stock Units on 09/30/2025.

The filing also discloses multiple recent sales during the prior three months by the named holder and related entities, including transactions on 09/30/2025, 09/24/2025, 09/10/2025, and 08/27/2025, with gross proceeds reported (for example, $10,952,733.12 on 09/30/2025). The filer certifies no undisclosed material information and references Rule 10b5-1 plans for some sales where indicated.

Positive

• Disclosure Compliance: Form 144 provides broker, share count, market value, and sale date as required
• 10b5-1 Transparency: Multiple past sales are labeled as 10b5-1, indicating pre-arranged trading plans for some transactions

Negative

• Concentration of recent insider sales: Multiple sales in the prior three months totaling several million dollars in proceeds could reduce insider holdings
• Short interval between acquisition and proposed sale: RSUs acquired 09/30/2025 are slated for sale ~one week later (10/07/2025)

Insights

Regulatory Compliance Analyst

TL;DR: A company insider plans a routine sale of newly vested RSUs; recent 10b5-1 sales are disclosed.

The filing records a proposed sale of 61,810 common shares valued at $8,273,268.50, acquired as restricted stock units on 09/30/2025. The notice follows the technical requirements of a Form 144 by providing broker details, outstanding share count (370,470,348), and an approximate sale date of 10/07/2025.

Dependence on previously adopted trading arrangements appears: several entries are labeled as 10b5-1 sales across 08/27/2025 to 09/30/2025, with individual gross proceeds listed. Monitor whether the planned sale occurs on the stated date and whether additional aggregated sales materially change insider ownership over the near term.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	61810	8273268.50	370470348	10/07/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2025	Restricted Stock Units	Issuer			61810	09/30/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/30/2025	78548	10952733.12
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/24/2025	32455	4223680.72
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/24/2025	50000	6506980.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/10/2025	32455	3840276.82
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/10/2025	50000	5916310.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/27/2025	32455	3104307.77
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/27/2025	50000	4782480.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CoreWeave's (CRWV) Form 144 announce?

It notifies the proposed sale of 61,810 common shares valued at $8,273,268.50, with an approximate sale date of 10/07/2025.

Who is handling the sale of the shares in the Form 144?

The broker listed is Morgan Stanley Smith Barney LLC at the address shown in the filing.

When were the shares to be sold acquired?

The shares were acquired as Restricted Stock Units on 09/30/2025 and recorded as the acquisition date in the filing.

Does the filing show recent related sales by the same person or entities?

Yes; the filing lists multiple sales in the past three months with dates including 09/30/2025, 09/24/2025, 09/10/2025, and 08/27/2025, and gross proceeds for each transaction.

What is the issuer's total outstanding share count reported?

The filing reports 370,470,348 shares outstanding.